Working… Menu

Gene Transfer for Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03282656
Recruitment Status : Suspended (Study paused per DSMB pending investigation of Adverse Event occurrence in an unrelated gene therapy study involving sickle cell patients.)
First Posted : September 14, 2017
Last Update Posted : February 21, 2021
Information provided by (Responsible Party):
David Williams, Boston Children's Hospital